[go: up one dir, main page]

IL136591A - Nasal pharmaceutical solutions - Google Patents

Nasal pharmaceutical solutions

Info

Publication number
IL136591A
IL136591A IL13659199A IL13659199A IL136591A IL 136591 A IL136591 A IL 136591A IL 13659199 A IL13659199 A IL 13659199A IL 13659199 A IL13659199 A IL 13659199A IL 136591 A IL136591 A IL 136591A
Authority
IL
Israel
Prior art keywords
pharmaceutical solutions
nasal pharmaceutical
nasal
liquid
inter alia
Prior art date
Application number
IL13659199A
Other languages
English (en)
Other versions
IL136591A0 (en
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of IL136591A0 publication Critical patent/IL136591A0/xx
Publication of IL136591A publication Critical patent/IL136591A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
IL13659199A 1998-01-30 1999-01-28 Nasal pharmaceutical solutions IL136591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98810069 1998-01-30
PCT/EP1999/000555 WO1999038492A1 (en) 1998-01-30 1999-01-28 Nasal solutions

Publications (2)

Publication Number Publication Date
IL136591A0 IL136591A0 (en) 2001-06-14
IL136591A true IL136591A (en) 2005-08-31

Family

ID=8235913

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13659199A IL136591A (en) 1998-01-30 1999-01-28 Nasal pharmaceutical solutions

Country Status (12)

Country Link
EP (1) EP1051155B1 (xx)
JP (1) JP4603687B2 (xx)
AT (1) ATE219657T1 (xx)
AU (1) AU741364B2 (xx)
CA (1) CA2311530C (xx)
DE (1) DE69901936T2 (xx)
DK (1) DK1051155T3 (xx)
ES (1) ES2180274T3 (xx)
IL (1) IL136591A (xx)
NZ (1) NZ505919A (xx)
PT (1) PT1051155E (xx)
WO (1) WO1999038492A1 (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
EP1194145B1 (de) * 1999-06-22 2003-02-05 Boehringer Ingelheim International Gmbh Stabile xylometazolin- und oxymetazolinlösung
DK1446119T3 (da) 2001-09-18 2006-07-10 Nycomed Danmark Aps Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse
BG65734B1 (bg) * 2002-02-22 2009-09-30 Био Терапютикс - Еоод Течен мукоадхезивен фармацевтичен състав
AU2003278962B2 (en) * 2002-06-20 2006-11-23 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol
AU2003272517A1 (en) 2002-09-13 2004-04-30 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
CA2530531A1 (en) 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
JP4956981B2 (ja) * 2005-01-05 2012-06-20 大正製薬株式会社 オキシメタゾリン含有水性組成物
GB2423711B (en) 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US8940796B2 (en) * 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
DE102008007198A1 (de) * 2008-02-01 2009-08-13 Infectopharm Arzneimittel Und Consilium Gmbh Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
US20120022032A1 (en) * 2008-10-10 2012-01-26 Schering Corporation Corticosteroid compositions and methods of treatments thereof
DE202013000748U1 (de) 2013-01-24 2013-02-19 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
EP2759290B1 (de) 2013-01-24 2019-11-06 Merz Pharma GmbH & Co. KGaA Sprühbare flüssige zubereitung zur nasalen anwendung mit erhöhter lokaler verweilzeit
DE102013001151A1 (de) 2013-01-24 2014-07-24 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
EP2978407B1 (en) * 2013-03-29 2020-05-06 Santa Farma Ilaç Sanayi A.S. Aqueous solution composition containing ipratropium and oxymetazoline
CN105358133B (zh) * 2013-07-17 2017-04-26 陶氏环球技术有限责任公司 用于施加到粘膜的包含羟烷基甲基纤维素的组合物
JP6073525B2 (ja) * 2013-09-25 2017-02-01 ダウ グローバル テクノロジーズ エルエルシー セルロースエーテルを含む粘膜に適用するための組成物
PL3236933T3 (pl) * 2014-12-24 2019-05-31 Jadran Galenski Laboratorij D D Kompozycja do podawania donosowego zawierająca wodę morską jako zaróbkę poprawiającą trwałość
JOP20190241B1 (ar) * 2017-04-17 2023-09-17 Hikma Pharmaceuticals Usa Inc مستحضرات رذاذ إبينيفرين
WO2019241401A1 (en) * 2018-06-13 2019-12-19 Insys Development Company, Inc. Epinephrine spray formulations
WO2020053609A1 (en) 2018-09-11 2020-03-19 Lead Biotherapeutics Ltd. Mucoadhesive dispersion nanoparticle system and method for production the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH04327533A (ja) * 1991-04-23 1992-11-17 Lion Corp 抗アレルギー用粘膜局所投与剤
EP0571671B1 (en) * 1992-05-26 1997-09-17 The Procter & Gamble Company A Pharmaceutical composition in powder form
CA2101126A1 (en) * 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
ATE241984T1 (de) * 1993-03-26 2003-06-15 Franciscus Wilhelmus He Merkus Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin
JPH07109228A (ja) * 1993-10-08 1995-04-25 Earth Chem Corp Ltd リゾチーム配合口腔用組成物
ATE249234T1 (de) * 1993-12-17 2003-09-15 Mochida Pharm Co Ltd Lösliches thrombomodulin enthaltende zubereitung
JP3269770B2 (ja) * 1995-03-02 2002-04-02 参天製薬株式会社 再分散性の優れたイオン性高分子配合水性懸濁点眼剤
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
WO1999016471A1 (en) * 1997-10-01 1999-04-08 Wakamoto Pharmaceutical Co., Ltd. O/w emulsion compositions

Also Published As

Publication number Publication date
IL136591A0 (en) 2001-06-14
CA2311530A1 (en) 1999-08-05
AU2519899A (en) 1999-08-16
DE69901936T2 (de) 2002-11-28
AU741364B2 (en) 2001-11-29
NZ505919A (en) 2002-10-25
DE69901936D1 (de) 2002-08-01
CA2311530C (en) 2008-06-10
DK1051155T3 (da) 2002-09-16
WO1999038492A1 (en) 1999-08-05
ES2180274T3 (es) 2003-02-01
JP4603687B2 (ja) 2010-12-22
PT1051155E (pt) 2002-10-31
ATE219657T1 (de) 2002-07-15
EP1051155B1 (en) 2002-06-26
EP1051155A1 (en) 2000-11-15
JP2002501884A (ja) 2002-01-22

Similar Documents

Publication Publication Date Title
IL136591A (en) Nasal pharmaceutical solutions
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
HUP0203556A2 (hu) Oxkarbazepint tartalmazó gyógyszerkészítmények és alkalmazásuk
ZA931470B (en) A pharmaceutical composition containing a defined lipid system.
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
IL119989A0 (en) Pharmaceutical compositions for oral treatment of multiple sclerosis
PL360254A1 (en) Pharmaceutical compositions
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
AU3227700A (en) Skin sanitizing compositions
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
BR0014355A (pt) Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
YU13301A (sh) Muskarinski agonisti i antagonisti
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
WO1996022305A3 (en) Modified peptides
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
IL138634A (en) Use of lasofoxifene for the prepartion of single dose medicament
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
GB2388777A (en) Compositions containing gangliosides for use in the treatment of skin disorders
GEP20043377B (en) Pharmaceutical Complex
MD1473G2 (ro) Remediu antiherpetic
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired